/

Other

/

Bavarian Nordic

Bavarian Nordic

Bavarian Nordic

Verified Nov 2026

Other

·

Copenhagen, Capital Region of Denmark

·

Since 1994

Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.

Bavarian Nordic

Verified Nov 2026

AT A GLANCE

Founded

1994

Headquarters

Copenhagen, Capital Region of Denmark

Employees

1,000-5,000

Ownership

Bavarian Nordic at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

1994

Headquarters

Copenhagen, Capital Region of Denmark

Industries

Automotive

Electric Vehicles

Medical

Military & Defense

Renewable Energy

Industrial Equipment

Overview

Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.

At a glance

Attribute

Detail

Founded

1994

Headquarters

Copenhagen, Capital Region of Denmark

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

What Bavarian Nordic makes

Bavarian Nordic manufactures vaccines for mpox, rabies, tick-borne encephalitis, cholera, and typhoid, with core capabilities in sterile manufacturing, lyophilization, and advanced vaccine formulations.

Latest developments

Facilities

Bavarian Nordic is headquartered in Copenhagen, Capital Region of Denmark. Public sources also reference these locations:

Company details

The company holds a market capitalization of approximately $2.24 billion and maintains strategic partnerships with the U.S. Government for biodefense applications. Bavarian Nordic was founded in 1994, has an estimated 1,000-5,000 employees, and is headquartered in Copenhagen, Capital Region of Denmark.

Frequently asked questions

What does Bavarian Nordic do?

Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.

Where is Bavarian Nordic headquartered?

Bavarian Nordic is headquartered in Copenhagen, Capital Region of Denmark (89 Vester Voldgade, Copenhagen, Capital Region of Denmark, 1552).

When was Bavarian Nordic founded?

Bavarian Nordic was founded in 1994.

How big is Bavarian Nordic?

Bavarian Nordic has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Copenhagen, Capital Region of Denmark (HQ)Headquarters · Denmark
Copenhagen, Capital Region of Denmark (HQ)89 Vester Voldgade, Copenhagen, Capital Region of Denmark, 1552, DenmarkHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.